High plasma dipeptidyl peptidase 3 levels are associated with mortality and organ failure in shock: results from the international, prospective and observational FROG-ICU cohort

Affiliations

• ¹ Department of Anesthesia, Burn and Critical Care, University Hospitals Saint-Louis - Lariboisière, AP-HP, Paris, France; UMR-S 942, INSERM, MASCOT, Paris University, Paris, France; Université de Paris, Paris, France; FHU PROMICE, AP-HP, Paris, France.
• ² Department of Anesthesia, Burn and Critical Care, University Hospitals Saint-Louis - Lariboisière, AP-HP, Paris, France; UMR-S 942, INSERM, MASCOT, Paris University, Paris, France.
• ³ Department of Intensive Care Medicine and Radboud Center for Infectious Diseases (RCI), Radboud University Medical Center, Nijmegen, The Netherlands.
• ⁴ UMR-S 942, INSERM, MASCOT, Paris University, Paris, France; Emergency Department, University Hospital of Beaujon, AP-HP, Clichy, France.
• ⁵ 4TEEN4 Pharmaceuticals GmbH, Hennigsdorf, Germany.
• ⁶ Sphingotec GmbH, Hennigsdorf, Germany.
• ⁷ Department of Anesthesia, Burn and Critical Care, University Hospitals Saint-Louis - Lariboisière, AP-HP, Paris, France; UMR-S 942, INSERM, MASCOT, Paris University, Paris, France; Université de Paris, Paris, France; FHU PROMICE, AP-HP, Paris, France. Electronic address: alexandre.mebazaa@aphp.fr.
• ⁸ Department of Anesthesia, Burn and Critical Care, University Hospitals Saint-Louis - Lariboisière, AP-HP, Paris, France; UMR-S 942, INSERM, MASCOT, Paris University, Paris, France; FHU PROMICE, AP-HP, Paris, France.
• ⁹ UMR-S 942, INSERM, MASCOT, Paris University, Paris, France; FHU PROMICE, AP-HP, Paris, France.